دسترسی نامحدود
برای کاربرانی که ثبت نام کرده اند
برای ارتباط با ما می توانید از طریق شماره موبایل زیر از طریق تماس و پیامک با ما در ارتباط باشید
در صورت عدم پاسخ گویی از طریق پیامک با پشتیبان در ارتباط باشید
برای کاربرانی که ثبت نام کرده اند
درصورت عدم همخوانی توضیحات با کتاب
از ساعت 7 صبح تا 10 شب
ویرایش: [3 ed.]
نویسندگان: Jeffrey MD Perlman MBChB
سری:
ISBN (شابک) : 0323543928, 9780323543927
ناشر: Elsevier
سال نشر: 2018
تعداد صفحات: 320
[294]
زبان: English
فرمت فایل : PDF (درصورت درخواست کاربر به PDF، EPUB یا AZW3 تبدیل می شود)
حجم فایل: 21 Mb
در صورت تبدیل فایل کتاب Neurology: Neonatology Questions and Controversies (Neonatology: Questions & Controversies) به فرمت های PDF، EPUB، AZW3، MOBI و یا DJVU می توانید به پشتیبان اطلاع دهید تا فایل مورد نظر را تبدیل نمایند.
توجه داشته باشید کتاب عصب شناسی: پرسش ها و بحث های مربوط به نوزادان (نوزادان: پرسش ها و بحث ها) نسخه زبان اصلی می باشد و کتاب ترجمه شده به فارسی نمی باشد. وبسایت اینترنشنال لایبرری ارائه دهنده کتاب های زبان اصلی می باشد و هیچ گونه کتاب ترجمه شده یا نوشته شده به فارسی را ارائه نمی دهد.
Purchase each volume individually, or get the entire 7-volume set, which includes online access that allows you to search across all titles! Gastroenterology and Nutrition Hematology, Immunology and Genetics Hemodynamics and Cardiology Infectious Disease and Pharmacology New Volume! Nephrology and Fluid/Electrolyte Physiology Neurology The Newborn Lung
Cover Series Page Neonatology Questions and Controversies Copyright Contributors Preface Series Foreword 1 - Cerebral Circulation and Hypotension in the Premature Infant: Diagnosis and Treatment Definition of Hypotension Pathogenesis and Diagnosis of Pathologic Cerebral Blood Flow Monitoring of Blood Pressure, Systemic and Organ Blood Flow, and Cerebral Function Doppler Ultrasound Impedance Electrical Cardiometry Near-Infrared Spectroscopy Amplitude-Integrated EEG (Cerebral Function Monitoring) Summary of the Monitoring Methods Discussed Treatment Strategies Systemic Hypotension Treatment of Hypotension Associated With PDA Treatment of Hypotension Associated With Other Causes Such as Sepsis, Adrenal Insufficiency, and Hypovolemia The Impact of Provision of Intensive Care on Systemic and Cerebral Hemodynamics Summary and Recommendations Diagnosis of Hypotension Treatment of Hypotension REFERENCES 2 - Intraventricular Hemorrhage and White Matter Injury in the Preterm Infant Background Neuropathology: Relevance to Clinical Findings Pathogenesis Periventricular White Matter Injury Associated With IVH Clinical Features Complications Prevention Perinatal Strategies Antenatal Steroids Pregnancy-Induced Hypertension Magnesium Sulfate Route of Delivery Delayed Cord Clamping Postnatal Strategies Postnatal Factors Associated With an Increased Risk Postnatal Administration of Medications to Reduce Severe IVH White Matter Injury in the Absence of Hemorrhage Periventricular Leukomalacia Pathogenesis Vascular Factors Intrinsic Vulnerability of the Differentiating Oligodendrocyte Free Radical Injury Excitotoxic Injury (Glutamate) Cytokines Maternal Fetal Infection and/or Inflammation and White Matter Injury Clinical Factors Associated With PVL Prevention Outcome Intraventricular Hemorrhage White Matter Injury Gaps in Knowledge Conclusions REFERENCES 3 - Posthemorrhagic Hydrocephalus Management Strategies Question 1: What Measurements of Ventricular Size Are Used in Diagnosis of PHVD Question 2: How Can Ventricular Dilation Driven By Cerebrospinal Fluid Under Pressure Be Distinguished From Ventricular Dilation... Question 3: How Is Excessive Head Enlargement Defined Question 4: How Is Raised Intracranial Pressure Recognized Question 5: What Is Infant A’s Prognosis Question 6: What Is the Mechanism of PHVD Question 7: How Can PHVD Injure White Matter Raised Intracranial Pressure, Parenchymal Compression, and Ischemia Free Radical‒Mediated Injury Proinflammatory Cytokines Loss of White Matter and Gray Matter Question 8: What Interventions Have Been Used in PHVD, and Is There Any Evidence That They Improve Outcome Ventriculoperitoneal Shunt Surgery Objectives in Treating PHVD Repeated Lumbar Punctures or Ventricular Taps Drug Treatment to Reduce CSF Production Intraventricular Fibrinolytic Therapy External Ventricular Drain Tapping Via an Ommaya Reservoir Ventriculosubgaleal Shunt Third Ventriculostomy Choroid Plexus Coagulation Drainage, Irrigation, and Fibrinolytic Therapy Stem Cell Therapy Conclusions Gaps in Knowledge REFERENCES 4 - Hypothermia for Neonatal Hypoxic-Ischemic Encephalopathy: Different Cooling Regimens and Infants Not Included in Prior Trials Rationale for Further Investigations of Therapeutic Hypothermia What Is the Optimal Temperature and Duration for Therapeutic Hypothermia How Late Can Hypothermia be Initiated? Should Infants With Mild HIE Receive Hypothermia Therapy? Should Hypothermia Be Used in Preterm Infants With HIE? How Should Cooling on Transport Be Conducted? Is Therapeutic Hypothermia Neuroprotective When Used in Low- and Middle-Income Countries Conclusions REFERENCES 5 - General Supportive Management of the Term Infant With Neonatal Encephalopathy Following Intrapartum Hypoxia-Ischemia Introduction Delivery Room Management Early Identification of Infants at Highest Risk for Development of Hypoxic-Ischemic Brain Injury Supportive Care Ventilation Maintenance of Adequate Perfusion Fluid Status Control of Blood Glucose Concentration Temperature Seizures Prophylactic Barbiturates Potential Neuroprotective Strategies Aimed at Ameliorating Secondary Brain Injury Oxygen Free Radical Inhibitors and Scavengers Excitatory Amino Acid Antagonists Magnesium Xenon Erythropoietin Gaps in Knowledge REFERENCES 6 - Focal Cerebral Infarction Perinatal Arterial Ischemic Stroke Epidemiology Risk Factors Maternal Risk Factors Antepartum and Intrapartum Risk Factors Placental Risk Factors Infant Factors Clinical Manifestations Fetal Ischemic Stroke Neonatal Arterial Stroke Ischemic Stroke in the Preterm Infant Presumed Perinatal Ischemic Stroke Imaging Arterial Ischemic Stroke Management of Perinatal Arterial Ischemic Stroke Cerebral Sinovenous Thrombosis Epidemiology Risk Factors for CSVT Clinical Manifestations Imaging CSVT Management of CSVT Hemorrhagic Stroke Clinical Features Hemorrhagic Stroke in Preterm Infants Imaging Hemorrhagic Stroke Management of Perinatal Hemorrhagic Stroke Evaluation of Newborns With Suspected Stroke History and Physical Examination Differential Diagnosis Approach to Investigations (Table 6.2) Neuroimaging Laboratory Investigations Electroencephalography Placental Pathology Neurologic Outcome Neuromotor Outcome Neonatal Seizures and Epilepsy Neurobehavioral Outcome Visual Function Stroke Recurrence Controversies in Neonatal Stroke Hematologic Investigations Therapeutic Hypothermia for Neonatal Stroke Anticoagulation for CSVT REFERENCES 7 - Diagnosis and Management of Acute Seizures in Neonates Diagnosis Classifications Focal Clonic Seizures Focal Tonic Seizures Myoclonic Jerks Autonomic Signs Spasms Subclinical Seizures Definition of Seizures Definition of Neonatal Status Epilepticus Controversies in Definition and Classification of Seizures Differential Diagnosis Diagnostic Tools and Monitoring EEG Characteristics of Neonatal Seizures Standard EEG Versus Long-Term or Continuous Monitoring Controversies in Monitoring Management Therapy Efficacy and Safety of Antiseizure Medications for Seizures Phenobarbital and Phenytoin Midazolam Lidocaine Levetiracetam Topiramate Antiepileptic Drug Treatment Duration and Discontinuation Hypothermia Controversies in Therapy “Newborn-Tailored” Pharmacotherapy Age-Appropriate Antiseizure Therapies Timing of Therapy Administration Predictors of Response to Antiseizure Medications Electrographic-Only Seizures Synergistic Effects of Hypothermia and Anticonvulsant Medications Conclusions REFERENCES 8 - Neonatal-Onset Epilepsies: Early Diagnosis and Targeted Treatment The New Chapter of Neonatal Epilepsies Landscape of the Neonatal Epilepsies KCNQ2/3-Associated Neonatal Epilepsies Epilepsy of Infancy With Migrating Focal Seizures Associated With KCNT1 SCN2A-Associated Neonatal Epilepsies The Promise and the Challenge of Precision Medicine in the Nursery REFERENCES 9 - Glucose and Perinatal Brain Injury—Questions and Controversies Glucose Metabolism in the Fetus and Newborn Preterm Infants Intrauterine Growth Restriction Cerebral Metabolism of Glucose Alternate Substrates to Glucose Glucose Transporters Definitions Controversy and Question Symptomatic Versus Asymptomatic Hypoglycemia Duration of Hypoglycemia Causes of Hypoglycemia Incidence Pathophysiology of Hypoglycemia Cerebral Blood Flow, Glucose Utilization, and Cerebral Energy Metabolism Cerebral Biochemical Alterations During Hypoglycemia Hypoglycemia and Brain Damage Neuroimaging Abnormalities Controversy and Question Hypoglycemia and Hypoxia-Ischemia, Seizures Case History Outcome Treatment Conclusions REFERENCES 10 - Hyperbilirubinemia and the Risk for Brain Injury Definition and Epidemiology History of KSD Prevalence Pathogenesis of Bilirubin Neurotoxicity Active Transport of Bilirubin Mechanisms of Bilirubin Damage Bilirubin and Calcium Homeostasis Mechanisms of Auditory Dysfunction Neuroprotective Action of Bilirubin Molecular Response to Hyperbilirubinemia Developmental Susceptibility Diagnosis: Acute Bilirubin Encephalopathy and Kernicterus Spectrum Disorders Suggested Improvements to the AAP Guidelines for the Treatment of Hyperbilirubinemia Acute Bilirubin Encephalopathy ABE and Auditory Nervous System ABE and Neuroimaging New Strategies in the Diagnosis of ABE Kernicterus Spectrum Disorders Diagnosis of Kernicterus Spectrum Disorders Recommendations for Prevention and Treatment Recommendation for the Prevention and Treatment of ABE Recommendation for the Diagnosis of KSD and Treatment of Its Clinical Manifestations Expanding the Idea of Kernicterus as a Spectrum of Disorders Bilirubin Neurotoxicity in the Very Premature Infant Difficulties in Assessing Kernicterus in Preterm Infants Genetics of KSDs and Susceptibility to Bilirubin Neurotoxicity Gaps in Knowledge Conclusion REFERENCES 11 - Neonatal Meningitis: Current Treatment Options Question 1: What Risk Factors Predispose This Infant to Have Early-Onset Bacterial Meningitis? Question 2: Do Infants With Meningitis Have Positive Blood Cultures? Question 3: What Is the Optimal Evaluation for Possible Late-Onset Sepsis in Preterm Infants in the NICU? Question 4: What Is the Empirical Antimicrobial Choice for Possible Late-Onset Sepsis in the NICU? Question 5: What Is the Treatment of Meningitis in Neonates, Particularly That Caused by Gram-Negative Bacilli? Question 6: Should Other Therapies Be Considered? Question 7: What Is the Duration of Treatment for Meningitis in Neonates? Question 8: When Should Neuroimaging Be Considered, and What Type of Examination Is Recommended? Question 9: Should Other Adjunctive Therapies Be Provided to an Infant With Meningitis? Question 10: What If the Infant’s CSF Is Abnormal but Routine Bacterial Cultures of CSF and Blood Are Sterile? Question 11: What Is the Outcome of Meningitis in Neonates? Conclusion REFERENCES 12 - Neonatal Herpes Simplex Virus, Congenital Cytomegalovirus, and Congenital Zika Virus Infections Question 1: When Does Infection Occur? Neonatal HSV Disease Congenital CMV Infection Congenital Zika Infection Question 2: What Are the Risk Factors for Neonatal Infection? Neonatal HSV Disease Congenital CMV Infection Congenital Zika Infection Question 3: What Are the Clinical Manifestations of Neonatal Infection and Disease? Neonatal HSV Disease Congenital CMV Infection Congenital Zika Infection Question 4: What Are the Treatments and Outcomes for HSV, CMV, and Zika Virus Infections in Neonates? Neonatal HSV Disease Congenital CMV Infection Congenital Zika Infection Question 5: Do All Infants With HSV and CMV Infections Have to Be Treated? Neonatal HSV Disease Congenital CMV Infection Congenital Zika Infection Question 6: What Is the Appropriate Diagnostic Approach to an Infant in Whom HSV, CMV, or Congenital Zika Infection Is Suspected? Neonatal HSV Disease Congenital CMV Infection Congenital Zika Infection Question 7: How Should You Monitor the Response to Treatment? Neonatal HSV Disease Congenital CMV Infection Congenital Zika Infection Question 8: What Are the Biggest Gaps in Our Current Understanding of the Natural History, Diagnosis, and Management of These Infections? Neonatal HSV Disease Congenital CMV Infection Congenital Zika Infection Conclusions REFERENCES 13 - Neonatal Hypotonia Clinical History Collection Clinical Evaluation Neurologic Examination of the Hypotonic Infant Diagnostic Investigation Most Common Neuromuscular Disorders Presenting With Congenital Hypotonia Spinal Muscular Atrophies Myopathies Congenital Muscular Dystrophies Congenital Myopathies Pompe Disease Congenital Myotonic Dystrophy Neuromuscular Junction Defects REFERENCES 14 - Amplitude-Integrated EEG and Its Potential Role in Augmenting Management Within the NICU Amplitude-Integrated EEG Assessment of aEEG Background Pattern Comparison With Standard EEG Background Pattern Prognostic Value of aEEG in HIE: Noncooled Situation Prognostic Value of aEEG in HIE: Cooled Situation aEEG and Seizures Seizure Detection Should We Treat Subclinical Seizures? aEEG in Preterm Infants Pitfalls and Artifacts Seizure-Like Artifacts aEEG in Other Clinical Conditions Gaps in Knowledge Conclusion REFERENCES 15 - Congenital Heart Disease: An Important Cause of Brain Injury and Dysmaturation Fetal Brain Injury and Maturation Prenatal Diagnosis Postnatal Diagnosis Malformation Grouping Transposition of Great Vessels Hypoplastic Left Heart Syndrome Brain Injury and Brain Maturation Cranial Ultrasound Versus MRI Cerebral Ischemia and Stroke White Matter Injury Cerebral Sinovenous Thrombosis Subdural Hemorrhage Brain Dysmaturation Neuromonitoring Intraoperative Monitoring Near-Infrared Spectroscopy Amplitude-Integrated Electroencephalography Continuous Electroencephalography Advanced Magnetic Resonance Imaging Techniques in Congenital Heart Disease MR Diffusion Tensor Imaging Magnetic Resonance Spectroscopy Functional MRI Other Techniques Neurodevelopment of the Infant With CHD Predictors of Outcomes Preoperative Factors Intraoperative Factors Postoperative Factors New Interventions and Neuroprotection Gaps in Knowledge REFERENCES 16 - Long-Term Follow-Up of the Very Preterm Graduate The Major Sequelae of Very Preterm Birth Cerebral Palsy Cognitive Impairment in Infancy Sensory Outcomes Behavior Classification of Impairment Learning Points Transition to School Starting School Emerging Impairments at Early School Age Cognitive Function School Attainment Behavior Motor Problems Changes Over Time for Individual Children Learning Points Transition to Young Adult Life Learning Points Components of a Follow-Up Program Gaps in Knowledge Conclusions REFERENCES